TTrialPathMatch Me to Trials
← Back to trials
RecruitingPleural Infection

Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic Effusion

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to see if there is any benefit in adding saline irrigation through a chest tube to the standard course of treatment for people diagnosed or suspected of having a pleural space infection.

Sponsor: Mayo Clinic

You may qualify if…

  • Purulent pleural fluid versus pleural fluid analysis demonstrating pH \<7.2, glucose \<60 mg/dL, positive Gram stain, or positive pleural fluid culture versus multiseptated pleural effusion with infection at top of differential diagnosis
  • Patients initiating intrapleural lytic therapy under the care of the Interventional Pulmonary consult service at Mayo Clinic in Rochester, MN

You may not qualify if…

  • Unwillingness to give informed consent
  • Patients with known bleeding diathesis
  • Platelet count \<50,000 per μL
  • INR \>2.2 (of note, INR can be allowed to drift down or be reversed pharmacologically prior to initiation of intrapleural lytics/saline)
  • Current use of systemic anticoagulation or antiplatelet therapy without the ability to hold therapy for the recommended amount of time prior to an invasive procedure (aspirin monotherapy is acceptable)
  • Pregnant or nursing females, or females of child-bearing potential who decline a pregnancy test prior to enrollment
  • Incarcerated patients
  • Presence of ipsilateral bronchopleural fistula

Where it's recruiting

Minnesota

Rochester

Source: ClinicalTrials.gov · NCT06434324 · last updated 2026-03-30

Pleural Space Saline Irrigation in Addition to Standard Intrapleural T · TrialPath